companydata.dkGLAXOSMITHKLINE PHARMA A/S
CVR: 27394019
Secondary names: WELLCOME DANMARK A/S, WELLCOME BIOTECHNOLOGY A/S, WELLCOME DIAGNOSTICS A/S
The financial health of GLAXOSMITHKLINE PHARMA A/S appears stable, with a consistent profit margin and a positive trajectory in revenue. In 2024, the company reported revenue of 548.47 million DKK and a profit of 12.24 million DKK, reflecting a growth trend from 474.48 million DKK in revenue and 12.00 million DKK in profit in 2023. Equity has also increased slightly to 38.13 million DKK, indicating a solid foundation for future growth. While the revenue growth is notable, the profit margins remain relatively stable, suggesting effective cost management. Positioned within the wholesale trade of pharmaceuticals and healthcare products, the company maintains a competitive stance in the industry.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at drive handel
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 548.5 mio. | 12.2 mio. | 99.1 mio. | 38.1 mio. | 73 | |
History
Ownership
Management
Directors
Board
Production units (2)
Similar companies
Companies in the same industry and area